AU2001277549A1 - Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses - Google Patents
Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necrosesInfo
- Publication number
- AU2001277549A1 AU2001277549A1 AU2001277549A AU2001277549A AU2001277549A1 AU 2001277549 A1 AU2001277549 A1 AU 2001277549A1 AU 2001277549 A AU2001277549 A AU 2001277549A AU 2001277549 A AU2001277549 A AU 2001277549A AU 2001277549 A1 AU2001277549 A1 AU 2001277549A1
- Authority
- AU
- Australia
- Prior art keywords
- necroses
- tumours
- plaques
- imaging
- representation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002872 contrast media Substances 0.000 title 1
- 238000003384 imaging method Methods 0.000 title 1
- 239000002184 metal Substances 0.000 title 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10040380.8 | 2000-08-11 | ||
| DE10040380A DE10040380B4 (en) | 2000-08-11 | 2000-08-11 | MRI contrast agent for visualization of plaque, lymph nodes, infarcted and necrotic tissue or both necrosis and tumors, comprising perfluoroalkylated metal complex having specific micelle forming properties |
| PCT/EP2001/008498 WO2002013874A2 (en) | 2000-08-11 | 2001-07-23 | Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2001277549A1 true AU2001277549A1 (en) | 2002-05-23 |
| AU2001277549B2 AU2001277549B2 (en) | 2007-02-08 |
Family
ID=7652860
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU7754901A Pending AU7754901A (en) | 2000-08-11 | 2001-07-23 | Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses |
| AU2001277549A Ceased AU2001277549B2 (en) | 2000-08-11 | 2001-07-23 | Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU7754901A Pending AU7754901A (en) | 2000-08-11 | 2001-07-23 | Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1307236A2 (en) |
| JP (1) | JP2004506025A (en) |
| KR (1) | KR20030022387A (en) |
| CN (1) | CN1469757A (en) |
| AR (1) | AR034139A1 (en) |
| AU (2) | AU7754901A (en) |
| BG (1) | BG107542A (en) |
| BR (1) | BR0113188A (en) |
| CA (1) | CA2419223A1 (en) |
| CZ (1) | CZ2003392A3 (en) |
| DE (1) | DE10066210B4 (en) |
| EE (1) | EE200300061A (en) |
| HR (1) | HRP20030173A2 (en) |
| HU (1) | HUP0300736A3 (en) |
| IL (1) | IL154385A0 (en) |
| MX (1) | MXPA03001287A (en) |
| NO (1) | NO20030604L (en) |
| NZ (1) | NZ523932A (en) |
| PL (1) | PL365596A1 (en) |
| RU (1) | RU2290206C2 (en) |
| SK (1) | SK1572003A3 (en) |
| TW (1) | TWI296931B (en) |
| UA (1) | UA82642C2 (en) |
| WO (1) | WO2002013874A2 (en) |
| YU (1) | YU10603A (en) |
| ZA (1) | ZA200301949B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7344704B2 (en) | 2002-07-10 | 2008-03-18 | Schering Ag | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi |
| DE10231799B4 (en) * | 2002-07-10 | 2006-10-05 | Schering Ag | Use of perfluoroalkyl-containing metal complexes as contrast agents in MR imaging for the presentation of intravascular thrombi |
| DE102005008309A1 (en) * | 2005-02-17 | 2006-08-24 | Schering Ag | Pharmaceutical agents containing fluoroalkyl-containing metal complexes and epothilones |
| DE102006021495A1 (en) * | 2006-05-09 | 2007-11-15 | Bayer Schering Pharma Ag | Use of metal chelate containing perfluorinated alkyl-residue, chelator-residue and metal ion equivalent to the atomic number, for the production of diagnostic agent for representation of amyloid-containing plaques |
| US7887835B2 (en) * | 2006-09-19 | 2011-02-15 | Fujifilm Corporation | Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound |
| DE102006049821A1 (en) | 2006-10-18 | 2008-04-24 | Bayer Schering Pharma Aktiengesellschaft | New, well tolerated metal chelates, for use as radiodiagnostic, radiotherapeutic or NMR and X-ray diagnostic agents, contain chelator and perfluorinated polyethylene glycol residues |
| DE102007015598A1 (en) * | 2007-03-29 | 2008-10-02 | Heinrich-Heine-Universität Düsseldorf | Use of fluorochemical compounds for diagnostic purposes using imaging techniques |
| JP2011190183A (en) * | 2010-03-11 | 2011-09-29 | Noguchi Institute | Fluorous sugar-bonded crown ether derivative |
| US9976072B2 (en) * | 2014-03-26 | 2018-05-22 | Chevron U.S.A. Inc. | Multicarboxylate compositions and method of making the same |
| EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
| CN115594579A (en) | 2016-09-14 | 2023-01-13 | 大金工业株式会社（Jp） | Branched fluorochemical compounds |
| CA3044877A1 (en) | 2016-11-28 | 2018-05-31 | Bayer Pharma Aktiengesellschaft | High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging |
| JOP20210114A1 (en) | 2018-11-23 | 2023-01-30 | Bayer Ag | Formulation of contrast media and process of preparation thereof |
| CN109867635A (en) * | 2019-02-14 | 2019-06-11 | 华东师范大学 | A kind of T1 type micella magnetic resonance imaging contrast and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19603033A1 (en) * | 1996-01-19 | 1997-07-24 | Schering Ag | Perfluoroalkyl-containing metal complexes, processes for their preparation and their use in NMR diagnostics |
| JPH10112939A (en) * | 1996-10-07 | 1998-04-28 | Nec Corp | Power switching circuit |
| DE19729013A1 (en) * | 1997-07-03 | 1999-02-04 | Schering Ag | Oligomeric, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnostics |
| US6019959A (en) * | 1997-07-31 | 2000-02-01 | Schering Aktiengesellschaft | Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis |
-
2000
- 2000-08-11 DE DE10066210A patent/DE10066210B4/en not_active Expired - Fee Related
-
2001
- 2001-07-23 CA CA002419223A patent/CA2419223A1/en not_active Abandoned
- 2001-07-23 NZ NZ523932A patent/NZ523932A/en unknown
- 2001-07-23 EE EEP200300061A patent/EE200300061A/en unknown
- 2001-07-23 PL PL01365596A patent/PL365596A1/en not_active Application Discontinuation
- 2001-07-23 WO PCT/EP2001/008498 patent/WO2002013874A2/en not_active Application Discontinuation
- 2001-07-23 HU HU0300736A patent/HUP0300736A3/en unknown
- 2001-07-23 CN CNA018172717A patent/CN1469757A/en active Pending
- 2001-07-23 CZ CZ2003392A patent/CZ2003392A3/en unknown
- 2001-07-23 RU RU2003105810/15A patent/RU2290206C2/en not_active IP Right Cessation
- 2001-07-23 IL IL15438501A patent/IL154385A0/en unknown
- 2001-07-23 MX MXPA03001287A patent/MXPA03001287A/en active IP Right Grant
- 2001-07-23 KR KR10-2003-7002023A patent/KR20030022387A/en not_active IP Right Cessation
- 2001-07-23 AU AU7754901A patent/AU7754901A/en active Pending
- 2001-07-23 EP EP01955366A patent/EP1307236A2/en not_active Withdrawn
- 2001-07-23 UA UA2003032067A patent/UA82642C2/en unknown
- 2001-07-23 SK SK157-2003A patent/SK1572003A3/en not_active Application Discontinuation
- 2001-07-23 JP JP2002519012A patent/JP2004506025A/en active Pending
- 2001-07-23 BR BR0113188-5A patent/BR0113188A/en not_active IP Right Cessation
- 2001-07-23 AU AU2001277549A patent/AU2001277549B2/en not_active Ceased
- 2001-07-23 YU YU10603A patent/YU10603A/en unknown
- 2001-08-10 TW TW090119643A patent/TWI296931B/en active
- 2001-08-10 AR ARP010103833A patent/AR034139A1/en unknown
-
2003
- 2003-02-07 NO NO20030604A patent/NO20030604L/en not_active Application Discontinuation
- 2003-02-07 BG BG107542A patent/BG107542A/en unknown
- 2003-03-10 HR HR20030173A patent/HRP20030173A2/en not_active Application Discontinuation
- 2003-03-10 ZA ZA200301949A patent/ZA200301949B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL370029A1 (en) | 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer | |
| PT1757606E (en) | Xanthinderivatives for use as medical agents and the preparation thereof | |
| IT1313599B1 (en) | METALLIC COMPLEXES USABLE IN THE CATALYSIS FOR THE (CO) POLYMERIZATION OF ALPHA-OLEFINS | |
| WO2002013874A8 (en) | Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses | |
| AU2001277549A1 (en) | Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses | |
| AU2001265296A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| PL367188A1 (en) | Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents | |
| EP1465997A4 (en) | Use of biomolecular targets in the treatment and visualization of tumors | |
| EP1482985A4 (en) | Technetium-dipyridine complexes, and methods of use thereof | |
| PL368458A1 (en) | Improved use of antitumoral compound in cancer therapy | |
| AU2001261544A1 (en) | Metal surface treatment agent | |
| EP1390689A4 (en) | Reducing coherent artifacts in an interferometer | |
| AU2002213883A1 (en) | Cr complexes and their use for the polymerization of alpha-olefins | |
| AU2003281146A1 (en) | Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of intravascular thrombes | |
| AU2002239431A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| AU2001292797A1 (en) | Metal complexes for use in medical and therapeutic applications | |
| AU2003233431A1 (en) | Protamine-adenoviral vector complexes and methods of use | |
| EP1416945A4 (en) | Improved heteropolymer complexes and methods for their use | |
| AU6022701A (en) | Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione | |
| AU2001249493A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| HUP0100318A3 (en) | Salicyli denaminoalcohol derivatives, their chiral copper complexes, their preparations and use of the latter | |
| CA2481005A1 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy | |
| AU2002357468A1 (en) | Use of 2-acylindoles in the treatment of tumors | |
| AU2002254524A1 (en) | Use of semenogelin in the diagnosis, prognosis and treatment of cancer | |
| AU2001274946A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer |